The abstract is read at the publisher; the summary is JClub's.
PathPrism, an interpretable histopathology framework, uncovered hundreds of spatial biomarkers predictive of survival and MSI, BRAF, and TP53 mutations in 7,000 colorectal cancer patients across 11 cohorts.
- Why it matters: Spatial biomarkers are needed for precision oncology, but whole-slide image complexity makes systematic discovery difficult, especially with models that lack interpretability.
- What they did: PathPrism encodes tissue architecture into pathologically informed spatial features to model prognosis, molecular alterations, and therapy response, then uses large language models to generate spatial-semantic hypotheses.
- The result: Using VirtualWSI for semantic perturbation in an interpretable biomarker atlas, PathPrism stratified chemotherapy benefit in stage II/III disease and supports scalable, interpretable discovery.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.